{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:49Z","timestamp":1786649809770,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To compare the efficacy and safety of micropulse transcleral cyclophotocoagulation (MP-TSCPC) using the original and revised pars plana probe in patients with glaucoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Retrospective review of records who underwent MP-TSCPC between August 2020 and July 2023. Patients aged &gt;12 years and with a minimum follow-up of 1 year were included. Success was defined as intraocular pressure (IOP) \u2265 6 and \u226421 mm Hg with the same or fewer antiglaucoma medications and a minimum of 20% IOP reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 21 eyes treated with the original probe and 22 eyes treated with the revised probe were included. Baseline characteristics were comparable between the two groups. Mean IOP reduced from 30.3 \u00b1 9.9 mm Hg to 21.8 \u00b1 8.2 and 20.2 \u00b1 7.5 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) mm Hg at 6 months and 1 year, respectively, with the original probe and from 26.1 \u00b1 8.4 mm Hg to 19.1 \u00b1 7.4 and 18.8 \u00b1 5.8 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.009) mm Hg at 6 months and 1 year, respectively, with the revised probe. The difference between the probes was not statistically significant at all-time points. The mean number of antiglaucoma medications reduced from 3.9 \u00b1 0.7 to 3.3 \u00b1 1 at 1 year (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.006) with the original probe and from 3.9 \u00b1 1.1 to 3.4 \u00b1 1.4 at 1 year (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.045) with the revised probe. The probability of qualified success at 1 year was 33.3% for the original probe and 40.9% for the revised probe (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.755).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>MP-TSCPC is a safe and effective treatment for reducing IOP with both the original and revised probes, but the efficacy is not long-lasting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_1803_25","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:00:14Z","timestamp":1767787214000},"page":"420-424","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of micropulse transcleral cyclophotocoagulation using the original and revised pars plana probe"],"prefix":"10.4103","volume":"74","author":[{"given":"Rohan","family":"Daniel","sequence":"first","affiliation":[{"name":"Department of Glaucoma, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premanand","family":"Chandran","sequence":"additional","affiliation":[{"name":"Department of Glaucoma, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S","family":"Uduman","sequence":"additional","affiliation":[{"name":"Biostatistician, Department of Glaucoma, Aravind Eye Hospital, Tirunelveli, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhipsa","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Glaucoma, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrunali","family":"Dhavalikar","sequence":"additional","affiliation":[{"name":"Department of Glaucoma, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh V","family":"Raman","sequence":"additional","affiliation":[{"name":"Department of Glaucoma, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"R1-20260417","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R2-20260417","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and mata-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"R3-20260417","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1442-9071.2010.02238.x","article-title":"Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma","volume":"38","author":"Tan","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"R4-20260417","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/IJG.0000000000001539","article-title":"Update on micropulse transscleral cyclophotocoagulation","volume":"29","author":"Sanchez","year":"2020","journal-title":"J Glaucoma"},{"key":"R5-20260417","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ogla.2022.09.004","article-title":"MicroPulse transscleral laser therapy dosimetry utilizing the revised P3 delivery device: A randomized controlled trial","volume":"6","author":"Balendiran","year":"2023","journal-title":"Ophthalmol Glaucoma"},{"key":"R6-20260417","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10384-022-00938-9","article-title":"Short-term outcomes of micropulse transscleral laser therapy using the revised delivery probe in refractory glaucoma","volume":"66","author":"Akiyama","year":"2022","journal-title":"Jpn J Ophthalmol"},{"key":"R7-20260417","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10103-024-04086-z","article-title":"Settings and effectiveness of the revised probe compared to the original probe for micropulse transscleral cyclophotocoagulation","volume":"39","author":"Hadjokas","year":"2024","journal-title":"Lasers Med Sci"},{"key":"R8-20260417","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5005\/jp-journals-10078-1460","article-title":"Outcomes of MicroPulse transscleral laser therapy using the revised MicroPulse P3 delivery device","volume":"18","author":"Ramachandran","year":"2024","journal-title":"J Curr Glaucoma Pract"},{"key":"R9-20260417","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/bjo.2005.083360","article-title":"Disc damage likelihood scale","volume":"90","author":"Henderer","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R11-20260417","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12886-023-03017-w","article-title":"The efficacy and safety of micropulse transscleral laser treatment in glaucoma: A systematic review and meta-analysis","volume":"23","author":"Ling","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"R12-20260417","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/IJG.0000000000001552","article-title":"Micropulse trans-scleral cyclophotocoagulation in patients with glaucoma: 1- and 2-year treatment outcomes","volume":"29","author":"de Crom","year":"2020","journal-title":"J Glaucoma"},{"key":"R13-20260417","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcjo.2022.10.012","article-title":"Safety and efficacy of micropulse transscleral cyclophotocoagulation: 2-year follow-up in a tertiary Canadian centre","volume":"59","author":"Khan","year":"2024","journal-title":"Can J Ophthalmol"},{"key":"R14-20260417","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/ceo.12360","article-title":"Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: A randomized exploratory study","volume":"43","author":"Aquino","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"R15-20260417","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5005\/jp-journals-10078-1427","article-title":"Clinical outcomes of MicroPulse transscleral laser therapy with the revised P3 delivery device","volume":"18","author":"Checo","year":"2024","journal-title":"J Curr Glaucoma Pract"},{"key":"R16-20260417","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ogla.2019.02.002","article-title":"Micropulse transscleral cyclophotocoagulation: A look at long-term effectiveness and outcomes","volume":"2","author":"Sarrafpour","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"R17-20260417","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41433-024-02929-1","article-title":"Cyclodiode vs micropulse transscleral laser treatment","volume":"38","author":"Kelada","year":"2024","journal-title":"Eye (Lond)"},{"key":"R18-20260417","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5005\/jp-journals-10078-1395","article-title":"Clinical outcomes of micropulse transscleral cyclophotocoagulation: 2 years of experience in Portuguese eyes","volume":"17","author":"Basto","year":"2023","journal-title":"J Curr Glaucoma Pract"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1803_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:40Z","timestamp":1786647520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1803_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1803_25","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"2025-07-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}